Charles and Lynn Schusterman Family Philanthropies
VC Fund
Charles and Lynn Schusterman Family Philanthropies is a VC fund focused on Artificial Intelligence and Machine Learning.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries Charles and Lynn Schusterman Family Philanthropies invests in
Artificial IntelligenceMachine LearningSaaSMedicalBig Data
Stages Charles and Lynn Schusterman Family Philanthropies invests in
Series ASeries BVenture - Series UnknownSeedSeries C
Countries Charles and Lynn Schusterman Family Philanthropies invests in
United StatesIsraelGermany
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alicia Meeks
|
|||
Charles Schusterman
|
|||
Julie Mikuta
|
|||
Lisa Eisen
|
|||
Investment Focus
Industry
- Artificial Intelligence 7 (47%)
- Machine Learning 4 (27%)
- SaaS 3 (20%)
- Medical 3 (20%)
- Big Data 3 (20%)
Stage
- Series A 5 (33%)
- Series B 5 (33%)
- Venture - Series Unknown 2 (13%)
- Seed 1 (7%)
- Series C 1 (7%)
Country
- United States 9 (60%)
- Israel 3 (20%)
- Germany 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alicia Meeks
Executive Administrative Assistant
|
Executive Administrative Assistant | Total investments: 0 | Find email | |
|
Charles Schusterman
Founder
|
Founder | Total investments: 0 | Find email | |
|
Julie Mikuta
President, Education
|
President, Education | Total investments: 0 | Find email | |
|
Lisa Eisen
National Director
|
National Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
retrain.ai
|
Retrain AI is a talent Intelligence platform that transforms the way organizations develop, upskill and reskill their employees using AI and Machine Learning algorithms. retrain's proprietary AI models capture business growth drivers, analyze skills and skill shift cycles, and predict the Jobs-of-the-Future, allowing expiring. The platformmaps the organization's skills inventory, quantifies talent gaps, and recommends personalized training pathways. | $14M / Venture - Series Unknown / Dec 14, 2022 | |
Pickle Robot
|
Pickle Robot is a low cost, collaborative package handling robot that automates several key tasks along the e-commerce supply chain.Package handling is a physically demanding job with extremely high rates of turnover. The rising costs of shipping, comprised of 2/3rds labor, have become a major bottleneck to continued growth in e-commerce.Dill is the first robot from the Pickle Robot Company. It works multiple shifts, communicates with its human collaborators, and is rapidly developing new skills in handling e-commerce parcels: such as loading/unloading of feeder trucks, palletizing/depalletizing, and preloading of last mile delivery vans, trucks, and parcel cars. | $26M / Series A / Nov 15, 2022 | |
Navina
|
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.Born from the vision of replacing the time-consuming chaos of patient data with a logical, actionable platform, Navina enables physicians to assess even the most complex cases in minutes. Its technology restructuresdisorganized data into an intelligible patient portrait, intuitively organized to support sophisticated and empathetic patient care. By leveraging AI and machine learning, the platform ensures that the most important information is immediately clear, diagnostically linked, and contextually surfaced, providing physicians with a comprehensive view of each patient’s data.The result is improved patient wellness and enhanced financial performance for both providers and payers. Navina is also a partner of the American Academy of Family Physicians (AAFP) Innovation Lab. | $22M / Series B / Oct 27, 2022 | |
Athletes Unlimited
|
Athletes Unlimited (AU) is a collection of basketball, softball, volleyball, lacrosse, and other sports leagues. They aim to empower athletes as leaders, promote inclusive ownership focused on the long-term financial and personal well-being of athletes, and bring fans closer to the game by innovating on and off the field. | $30M / Venture - Series Unknown / Sep 29, 2022 | |
Voyantis
|
Voyantis is a provider of an AI-driven growth platform for customer acquisition and lifecycle optimization. The company allows businesses to acquire, retain, and nurture high-value customers with precision and efficiency. It integrates predictive and prescriptive AI to eliminate the guesswork traditionally involved in assessing a customer’spotential value and delivers the user automated actions on the next steps and execution timing. | $19M / Seed / Jul 05, 2022 | |
Massive Bio
|
Massive Bio, is an Artificial Intelligence (AI) powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio combines technology, services and oncologysub-specialist expertise to maximize trial enrollment. Massive Bio is the first company that attacks controlling patient enrollment value chain; Massive Bio does patient identification through direct direct and indirect patient acquisition channels, pre-screening through virtual site, Just-In-Time (JIT) site activation and further analyzes real world data for drug discovery. One of the major differentiating point of Massive Bio is that the Company tackles “last mile” issues for trial enrollment to eliminate site and/or financial considerations of patients. Massive Bio is the go to partner for pharmaceutical companies and CROs to get the right patient at the right time. | $16.5M / Series A / Jun 02, 2022 | |
ConcertoCare
|
ConcertoCare serves patients with Medicare+Medicaid, Medicare Advantage or Medicare, who have complex care needs and an existing primary care provider (PCP). Patients keep their existing doctors and benefit plans. | $105M / Series B / Feb 03, 2022 | |
|
Navina
|
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.Born from the vision of replacing the time-consuming chaos of patient data with a logical, actionable platform, Navina enables physicians to assess even the most complex cases in minutes. Its technology restructuresdisorganized data into an intelligible patient portrait, intuitively organized to support sophisticated and empathetic patient care. By leveraging AI and machine learning, the platform ensures that the most important information is immediately clear, diagnostically linked, and contextually surfaced, providing physicians with a comprehensive view of each patient’s data.The result is improved patient wellness and enhanced financial performance for both providers and payers. Navina is also a partner of the American Academy of Family Physicians (AAFP) Innovation Lab. | $15M / Series A / Oct 18, 2021 | |
Creapaper
|
Creapaper develops an innovative raw material for paper production that is made mostly out of grass fiber. They provide the paper industry with a new raw material for the production of paper and cardboard – grass! Or, to be more precise, it’s actually dried hay. It is prepared using their own patented process according to the requirements of thecorresponding paper mill and is then incorporated into its production cycle as a raw material instead of virgin fibres (wood) or recycled paper. If wood is substituted by grass as a raw material for the production of paper and cardboard, CO2 emissions arising from the manufacturing process are reduced by up to 75%. | $23.2M / Series B / Oct 05, 2021 | |
Syng
|
Syng is an audio company transforming the human relationship with sound. their hardware and software platform gives creators and listeners the power to engage with, explore, and share sound in transformative new ways. | $48.8M / Series A / Sep 23, 2021 | |
| See all 15 investments → | |||
Co-Investors
Charles and Lynn Schusterman Family Philanthropies
14 deals together
Ranpak
3 deals together
.406 Ventures
2 deals together
Grove Ventures
2 deals together
Hetz Ventures
2 deals together
JS Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Artificial intelligence Investors
40,702 investors
Medical Investors
18,848 investors
Machine Learning Investors
17,935 investors
Big Data Investors
10,744 investors
SaaS VC Funds
61,208 investors
Health Care VC Funds
32,370 investors
Artificial intelligence VC Funds
27,398 investors
FAQ
What does Charles and Lynn Schusterman Family Philanthropies invest in?
Charles and Lynn Schusterman Family Philanthropies invests primarily in Artificial Intelligence, Machine Learning and SaaS startups, most often at Series A and Series B stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Charles and Lynn Schusterman Family Philanthropies?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Charles and Lynn Schusterman Family Philanthropies?
The team at Charles and Lynn Schusterman Family Philanthropies includes Alicia Meeks (Executive Administrative Assistant), Charles Schusterman (Founder) and Julie Mikuta (President, Education). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
